Inhibitory Smad7: emerging roles in health and disease

Marco A Briones-Orta1, Angeles C Tecalco-Cruz, Marcela Sosa-Garrocho

  • 1Departamento de Biología Celular y Desarrollo, Instituto de Fisiología Celular. Universidad Nacional Autónoma de México.

Insights

Smad7 protein inhibits Transforming Growth Factor-beta (TGF-β) signaling and integrates other pathways. Dysregulation of Smad7 impacts homeostasis and disease, making it a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Smad7 is an inhibitory Smad protein regulating Transforming Growth Factor-beta (TGF-β) signaling via negative feedback.
  • Smad7 also mediates crosstalk between TGF-β and other critical signaling pathways.
  • Upregulation of Smad7 follows TGF-β signaling, where it binds the TGF-β type I receptor, inhibiting R-Smad phosphorylation.

Purpose of the Study:

  • To review the known functions of Smad7.
  • To emphasize the role of Smad7 alterations in maintaining homeostasis.
  • To describe emerging roles of Smad7 in human diseases and its potential as a therapeutic target.

Main Methods:

  • Literature review of Smad7 functions.
  • Analysis of Smad7's role in TGF-β signaling.
  • Investigation of Smad7's involvement in physiological and pathological processes.

Main Results:

  • Smad7 antagonizes TGF-β-regulated cellular processes like proliferation, differentiation, apoptosis, adhesion, and migration.
  • Smad7 induction by cytokines is crucial for integrating various signaling pathways.
  • Altered Smad7 function is implicated in homeostasis and diseases such as fibrosis and cancer.

Conclusions:

  • Smad7 is a key regulator of physiological events and pathological processes.
  • Emerging evidence highlights Smad7's role in human diseases.
  • Smad7 represents a promising therapeutic target for diseases involving TGF-β signaling dysregulation.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...